Results 231 to 240 of about 43,657 (340)

Dominance and toxicity without lethality: Exploring biomass, cyanometabolites, and Daphnia responses across Cyanobacterial strains

open access: yesJournal of Phycology, EarlyView.
Abstract Cyanobacteria are cosmopolitan, important components of biomass with a remarkable ability to synthesize a diverse array of bioactive compounds, some of which may have toxic effects on other organisms and ecosystems. In this study, filamentous cyanobacterial strains isolated predominantly from temperate European freshwaters (Aphanizomenon ...
Łukasz Wejnerowski   +14 more
wiley   +1 more source

A review of microplastic contamination in the cryosphere. [PDF]

open access: yesiScience
Qayoom I   +5 more
europepmc   +1 more source

Evaluating Navigational Information and Data Needs to Support Safe Shipping in Canadian Arctic Waters

open access: green
Jean Holloway   +5 more
openalex   +2 more sources

Pharmacokinetics of Long‐Acting Ampicillin and Its Impact on the Gut Microbiome and Resistome in Rhesus Macaques (Macaca mulatta)

open access: yesJournal of Veterinary Pharmacology and Therapeutics, EarlyView.
ABSTRACT Injectable antimicrobials with documented prolonged dosing intervals (> 48 h) for use in rhesus macaques are sparse. The objective of our study was to assess the pharmacokinetics, urine excretion, and effects on gut microbiome and resistome of intramuscular administered long‐acting formulation of ampicillin (Albipen LA) in macaques.
Annemiek Maaskant   +9 more
wiley   +1 more source

Clam research in Nunavut: A scoping review of the literature. [PDF]

open access: yesOne Health
Gerend S   +7 more
europepmc   +1 more source

Effects of Oral Single‐Dose Empagliflozin on Urinary Glucose, Serum β‐Hydroxybutyrate, and Plasma Empagliflozin Concentrations in Healthy Adult Dogs

open access: yesJournal of Veterinary Pharmacology and Therapeutics, EarlyView.
ABSTRACT Empagliflozin is a sodium‐glucose cotransporter‐2 inhibitor used for treating humans with heart failure, among other conditions. This drug could have applications in veterinary cardiology, but whether empagliflozin has biological effects in dogs when administered at dosages approximating human therapeutic dosages is unknown.
Andrea D. Plá Gutierrez   +5 more
wiley   +1 more source

Expanding knowledge of mosquito (Diptera: Culicidae) and California serogroup viruses distributions in the North American Arctic. [PDF]

open access: yesJ Med Entomol
Villeneuve CA   +10 more
europepmc   +1 more source

Pharmacokinetics of 2 mg/kg Bupivacaine in a Rectus Abdominis Sheath Block in Horses

open access: yesJournal of Veterinary Pharmacology and Therapeutics, EarlyView.
ABSTRACT Administering large volumes of bupivacaine in the rectus abdominis sheath (RAS) block in horses could cause local anesthetic toxicity. This study aimed to evaluate the pharmacokinetics of 2 mg/kg bupivacaine in RAS blocks and the associated toxicity risk.
Daniel M. Sakai   +7 more
wiley   +1 more source

Arctic Diatoms as a Source of Antibiofilm Compounds: Identification of Methyl 3-Hydroxyoctadecanoate and Pheophorbide <i>a</i>. [PDF]

open access: yesBiomolecules
Huizer M   +9 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy